PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Paré, Guillaume
TI  - CURE ACTIVE: No Loss of Clopidogrel Efficacy with the CYP2C19 Loss-of-Function Allele in Patients with ACS or AF
DP  - 2010 Dec 01
TA  - MD Conference Express
PG  - 33--34
VI  - 10
IP  - 8
4099  - http://mdc.sagepub.com/content/10/8/33.2.short
4100  - http://mdc.sagepub.com/content/10/8/33.2.full
AB  - Genetic variations that are related to clopidogrel metabolism did not diminish clopidogrel efficacy in patients with acute coronary syndromes or atrial fibrillation, according to new data from the Clopidogrel in Unstable Angina to Prevent Recurrent Events [CURE] and Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events [ACTIVE] trials.